Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen Secures $25M Loan to Build Out California Facility

NEW YORK, July 1 - Deltagen said today it has secured a loan for $25 million to help it build-out its Redwood City, Calif. research facility.

 

The loan, made with Silicon Valley Bank, comprises a one-year $5 million accounts-receivable loan and a $20 million term loan that may be draw on March 2003 and that will mature in March 2007, Deltagen said in a statement.

 

Deltagen had about $35 million in cash and cash equivalents as of March 31.

 

Click here for more information.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.